#aacr

[theotherblueeyedtallest]

Cerulean tries her luck with Axel since the Purple in her universe is spoken for

Tallest Axel belongs to @thunderclaw100

[pathologylab]

Discover the cutting-edge world of #GeneticTesting with #G2M! Our portfolio boasts over 27 Next-Generation #Sequencing (NGS) Panels, covering a wide spectrum of #genetic and somatic disorders, including cancer. These #panels are compatible with the major sequencing platforms available in the market. All our panels are complemented with the data #analysis and reporting #software - CliSeq Interpreter. 👉 To know more about the NGS Solutions, join us at #AACR 2024, San Diego, California from 07-10th Apr'24 (Booth #853). Our team is ready to offer insights, answer questions, and explore collaborations. Click here to book your meeting slot https://www.genes2me.com/upcoming-events For more details, Call us at +91-8800821778 or drop us an email at social@genes2me.com #g2m #ngs #software #solutions #conference #meeting #testing #diego #california #GENES2ME #cliseq #nextgenerationsequencing #rtpcr #pcr

[softshelldabbles]

𝘼𝙩 𝙖 𝘾𝙧𝙤𝙨𝙨𝙧𝙤𝙖𝙙𝙨 ! 𝘼𝙐

𝐁𝐚𝐬𝐞𝐝 𝐢𝐧 𝐚 𝐭𝐢𝐦𝐞𝐥𝐢𝐧𝐞 𝐰𝐞𝐫𝐞 𝐭𝐡𝐞 𝐓𝐮𝐫𝐭𝐥𝐞𝐬 𝐝𝐨𝐧'𝐭 𝐞𝐱𝐢𝐬𝐭. 𝐋𝐢𝐟𝐞 𝐬𝐞𝐞𝐦𝐢𝐧𝐠𝐥𝐲 𝐠𝐨𝐞𝐬 𝐨𝐧 𝐧𝐨𝐫𝐦𝐚𝐥𝐥𝐲 𝐛𝐮𝐭 𝐨𝐧𝐜𝐞 𝐚 𝐟𝐫𝐞𝐚𝐤 𝐬𝐨𝐥𝐚𝐫 𝐬𝐭𝐨𝐫𝐦 𝐡𝐚𝐩𝐩𝐞𝐧𝐬 𝐓𝐮𝐫𝐭𝐥𝐞𝐬 𝐟𝐫𝐨𝐦 𝐦𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐝𝐢𝐦𝐞𝐧𝐬𝐢𝐨𝐧𝐬 𝐟𝐥𝐨𝐨𝐝 𝐢𝐧𝐭𝐨 𝐭𝐡𝐞 𝐭𝐢𝐦𝐞𝐥𝐢𝐧𝐞 𝐚𝐧𝐝 𝐡𝐚𝐯𝐞 𝐭𝐨 𝐟𝐢𝐧𝐝 𝐭𝐡𝐢𝐞𝐫 𝐰𝐚𝐲 𝐡𝐨𝐦𝐞 𝐰𝐢𝐭𝐡 𝐭𝐡𝐞 𝐡𝐞𝐥𝐩 𝐨𝐟 𝐚 𝐟𝐞𝐰 𝐧𝐞𝐰 𝐟𝐫𝐢𝐞𝐧𝐝𝐬. 𝐀𝐧𝐝 𝐧𝐞𝐰 𝐟𝐨𝐞𝐬 𝐩𝐥𝐚𝐧 𝐭𝐨 𝐬𝐭𝐨𝐩 𝐭𝐡𝐞𝐦 𝐚𝐬 𝐰𝐞𝐥𝐥.

[ 𝐁𝐚𝐬𝐢𝐜𝐚𝐥𝐥𝐲 𝐚 𝐡𝐮𝐠𝐞 𝐜𝐫𝐨𝐬𝐬𝐨𝐯𝐞𝐫 𝐞𝐯𝐞𝐧𝐭 𝐥𝐦𝐚𝐨 ]

𝐎𝐮𝐫 𝐦𝐚𝐢𝐧 𝐩𝐞𝐨𝐩𝐥𝐞 𝐨𝐟 𝐢𝐧𝐭𝐞𝐫𝐞𝐬𝐭 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐚𝐮 𝐜𝐞𝐧𝐭𝐞𝐫𝐬 𝐚𝐫𝐨𝐮𝐧𝐝 𝐀𝐩𝐫𝐢𝐥 , 𝐂𝐚𝐬𝐞𝐲 , 𝐚𝐧𝐝 𝐦𝐲 𝐎𝐂 𝐋𝐢𝐧. 𝐀𝐥𝐥 𝐛𝐞𝐢𝐧𝐠 𝐇𝐢𝐠𝐡𝐬𝐜𝐡𝐨𝐨𝐥 𝐬𝐭𝐮𝐝𝐞𝐧𝐭𝐬 𝐰𝐡𝐨 𝐚𝐫𝐞 𝐜𝐥𝐨𝐬𝐞 𝐟𝐫𝐢𝐞𝐧𝐝𝐬 𝐟𝐨𝐫 𝐲𝐞𝐚𝐫𝐬.

[ wish I could draw thier designs lmao but I can't draw XD ]

𝐓𝐮𝐫𝐭𝐥𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐀𝐔

𝐑𝐢𝐬𝐞

𝐁𝐚𝐲𝐯𝐞𝐫𝐬𝐞

𝟐𝟎𝟎𝟑

𝟐𝟎𝟎𝟕

𝟏𝟗𝟗𝟎

𝟐𝟎𝟏𝟐

𝐌𝐮𝐭𝐚𝐧𝐭 𝐌𝐚𝐲𝐡𝐞𝐦

𝐌𝐌𝐏𝐑 / 𝐈𝐃𝐖

𝐋𝐚𝐬𝐭 𝐑𝐨𝐧𝐢𝐧

[meowizard]

this image is all you need to know about my ace attorney au

[importantwomensbirthdays]

Beatrice Mintz

Cancer researcher Beatrice Mintz was born in New York City in 1921. In 1960, Mintz joined the Fox Chase Cancer Institute of Philadelphia, and went on to become one of its most celebrated researchers. She made groundbreaking discoveries in multiple areas of biology, including epigenetics, embryology, developmental genetics, and gene-transfer technology. Mintz's experiments on mice paved the way for potentially less toxic approaches to cancer treatment, and made it easier for scientists to study melanoma. In recognition of her achievements, she received numerous awards, including the Award for Lifetime Achievement in Cancer Research from the AACR, and the American Cancer Society's National Medal of Honor for Basic Research. Mintz was also nominated twice for a Nobel Prize.

Beatrice Mintz died in 2022 at the age of 100.

Image: Smithsonian Institution

[thoughtlessarse]

People born in or after 1965 might be experiencing accelerated aging in their cells. This trend could be contributing to the rise in early-onset cancers among people younger than 55, according to new research presented at the American Association for Cancer Research (AACR) Annual Meeting. “There are people that age more rapidly for a variety of different reasons, and their biological age tends to exceed their chronological age,” said Douglas E. Vaughan, MD, director of the Potocsnak Longevity Institute at Northwestern University Feinberg School of Medicine, who was not involved in the study. Researchers estimate that genetics only accounts for 25% of the variability in human longevity. Younger generations may experience accelerated aging because of early exposure to risk factors like stress and environmental influences. Some scientists want to slow biological aging as a way to prevent early-onset cancer and a number of other chronic diseases, like dementia and heart disease. “If you slow down aging, maybe just a little bit, we might be able to push back the onset of aging-related diseases and give people a longer health span as opposed to a longer lifespan,” Vaughn said.

continue reading

How many new chemicals have been introduced since 1965? How breathing and drinking micro- and nanoplastics, and PFAS contribute to this accelerated ageing?

[rayraystudies]

Over the weekend I was at a conference in Boston (the AACR special ovarian cancer conference) which was incredibly interesting - my hands actively hurt from writing notes the whole time. I also presented my research in a poster which was very useful in getting some good, constructive feedback.

✍ Archer & Olive Bullet Journal, Uniball Signo RT1 UMN-155, Pentel Fude Touch Brush Sign Pen, Tombow Dual Brush Pens

ig: rayraystudies|| links: carrd

[esseha]

Mise en garde de l'Association américaine pour la recherche sur le cancer

Le dernier rapport de l��Association américaine pour la recherche sur le cancer (AACR), publié le 7 septembre 2024 et relayé par le Daily Mail, souligne une réalité inquiétante : le cancer touche de plus en plus d’adolescents et de jeunes adultes. Les chercheurs ont identifié six facteurs clés qui contribuent à ce phénomène. Tout d’abord, une alimentation déséquilibrée se révèle particulièrement…

[softshelldabbles]

Lin: * literally bout to have a panic attack after seeing the Turtles for the first time *

April: * lowkey just vibin. More amazed this is happening in the first place * ( totally not high as fuck lol )

Casey: * just ready to fight lets be honest - lin gotta hold him back *

[almadengenomics]

The Almaden Genomics team participated in the American Association for Cancer Research Annual Meeting. AACR plays a pivotal role in advancing our understanding of cancer and facilitating the exchange of cutting-edge research in the field, and its annual meeting showcases the best cancer science and medicine from institutions worldwide.

[wavenyan]

桜のAACR

桜のアルプスあづみのセンチュリーライドにWAVE ONEとKAPELMUURがW出店するよ！遊びに来てネ♪

●ニャンさんグッズ盛りだくさん！→https://wavenyan.com/goods

●ウエイブニャン公式サイト→http://wavenyan.com/

●ウエイブニャンLINEスタンプ発売中！→http://urx.blue/NTgo

●ピクシブ→https://pixiv.me/user_mxcr8474

●インスタグラム→https://www.instagram.com/wavenyan/

#AACR #ねこ #猫 #桜のアルプスあづみのセンチュリーライド #桜のAACR #あずみのセンチュリーライド #AACR #カワイイ #イラスト #キャラクター #WAVEONE #ウエイブワン #ウエイブニャン #CoolJapan #Picturebook #Cat

[thecazagroup]

NEWLISTING #RENTAL

🏠 in #GreatFalls VA 22066 1034 Walker Mill Rd 4 🛏 2.5🛁 $4,850

✅Unparalleled Luxury Living in the heart of the sought-after Langley School District ✅Featuring 4 expansive bedrooms, 3 updated baths, nestled on a sprawling 1-Aacre Lot ✅Offers over 2,400 SF of Elegant Living Space ✅Highlighted by 2 wood-burning fireplaces, hardwood floors, and marble finishes ✅Grand layout includes an expansive unfinished basement, a 2-car garage, and a long driveway ✅Complemented by a convenient office/playroom on the Main Level ✅Perfect for multi-generational living with spacious En Suite bedrooms and abundant storage ✅Don't miss out on immediate occupancy of this Majestic Home

☎️ 703.337.3699 #TheCAZAGroup creates #RavingFans by helping our community make smarter #HomeBuying and #HomeSelling decisions with less hassle and better service. We're serious about helping you make excellent and informed decisions. #SatisfactionGuarantee #RealEstate Click for details 👉 https://www.thecazagroup.com/

[jcnnewswire]

Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024

http://dlvr.it/T5JYbB

[thxnews]

Innovent Revolutionizes Cancer Care at AACR

At the 2024 AACR Meeting, Innovent Biologics will unveil groundbreaking preclinical data on novel bispecific antibodies and ADCs, heralding a significant advancement in oncology and promising new, effective cancer treatments. This represents a pivotal moment in the fight against cancer.  

IBI3001: The Vanguard of Innovent's Arsenal

At the heart of Innovent's presentation is IBI3001, a novel anti-cancer drug that embodies the cutting-edge of therapeutic design. This site-specific glycan-conjugated B7-H3/EGFR bispecific ADC aims at tackling multiple solid tumors with unprecedented precision.   Dr. Kaijie He, Innovent's Vice President,  stated: “We are pleased that the pre-clinical studies of our novel anti-cancer drugs are accepted for Late-Breaking Research poster presentation at the 2024 AACR conference. This is the result of dedicated work from scientists at Innovent Academy with the aim to tackle cancers with innovative drugs that are more effective and safer. With careful design and optimization, our molecules can achieve favorable therapeutic windows of 40 to more than 200 times. We look forward to their performance in clinical settings and hope that these innovations can eventually benefit cancer patients.”  

A Spectrum of Innovation

In addition to IBI3001, Innovent is gearing up to reveal preclinical findings on a TROP2-targeted immune stimulating antibody conjugate (ISAC). This novel molecule demonstrates potent anti-tumoral activity coupled with an acceptable safety profile, promising a brighter future for cancer patients. Dr. He is optimistic about the therapeutic windows these innovations could open, with favorable ratios ranging from 40 to over 200 times, underscoring their potential efficacy in clinical settings.   The Bigger Picture: Confronting Cancer Cancer's toll on global health remains staggering, with millions of lives claimed annually. It's a battle fought on multiple fronts: genetic predispositions, lifestyle factors, and the dire need for effective treatments. Herein lies the importance of Innovent's work, aiming not only to extend the frontier of cancer treatment but also to offer hope to those embroiled in this fight. The company's contributions to early detection and treatment could significantly alter the landscape of cancer care, emphasizing the importance of continuous innovation in the medical field.  

Toward a Future Without Cancer

Innovent Biologics' presentation at the 2024 AACR Annual Meeting stands as a testament to the relentless pursuit of medical advancement. As we edge closer to unraveling the complexities of cancer, the contributions of companies like Innovent illuminate the path forward, promising a future where cancer's grip on humanity is significantly weakened.   Sources: THX News & Innovent Biologics, Inc.. Read the full article

[vietnamstar]

Huahui Health to Present Preclinical Data of HH018-sesutecan at the 2024 AACR Annual Meeting

BEIJING, April 4, 2024 /PRNewswire/ — Huahui Health Ltd.("Huahui Health"), a clinical stage biotechnology company focused on discovering and developing virology, hepatology, and oncology therapies, announced that it will present the results of preclinical data of HH018-sesutecan, a tumor microenvironment targeting CD98-directed ADC, at the American Association for Cancer Research (AACR) Annual…